section name header

Use and Dosing

Adult Dosingnavigator.gif

Multiple myeloma

Epithelial ovarian cancer

Note: Multiple dosing protocols have been recommended. Adjust dosing according to the clinical condition, hematological status and tolerance for each individual patient

Pediatric Dosingnavigator.gif


[Outline]

Indications

Contraindications

Black Box Warnings

Dosing Adjustment

Renal Dose Adjustment

Hepatic Dose Adjustment

Warnings/Precautions

Cautions: Use cautiously in

Pregnancy/Breast Feeding

Pregnancy Category:D

Breastfeeding: Most sources consider breastfeeding to be contraindicated with antineoplastic therapy. Due to the potential to cause serious adverse events, it is recommended that patients receiving melphalan should not breastfeed

Adverse Reactions

Clinical Pharmacology

Brands and Availability

flag_usa32.png

US Trade Name(s)

US Availability

Alkeran

flag_canada32.png

Canadian Trade Name(s)

Canadian Availability

Alkeran

flag_uk32.png

UK Trade Name(s)

UK Availability

Alkeran

flag_australia32.png

Australian Trade Name(s)

Australian Availability

Alkeran


[Outline]

flag_usa32.pngflag_canada32.pngflag_uk32.pngflag_australia32.png

Classification

Hematology/Oncology

Antineoplastics
Alkylating Agents

Pricing

Pricing data from www.DrugStore.com in U.S.A.

Warning.gifWarning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.

Pill

Drug Name: Alkeran 2 MG Oral Tablet

Ingredient(s): Melphalan

Imprint: GX;EH3;A

Color(s): White

Shape: Round

Size (mm): 7.00

Score: 1

Inactive Ingredient(s): colloidal silicon dioxide / crospovidone / hypromellose / polyethylene glycol 400 / magnesium stearate / cellulose, microcrystalline / titanium dioxide

Drug Label Author:
GlaxoSmithKline LLC

DEA Schedule:
Non-Scheduled